MET and cancer: HGF activation by matriptase and the subsequent induction of c‐Met pathway contribute to the progression of cancers.17, 18, 19 Thus, a rational strategy to suppress HGF activity in cancers is to inhibit its matriptase‐mediated maturation from pro‐HGF.